跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要聚焦元分析异质性指标的统计计算,未充分对应所给领域细分。

反馈分类问题

Quantifying inconsistency in one-stage individual participant data meta-analyses of treatment-covariate interactions: a simulation study

单阶段个体参与者数据元分析中治疗与协变量交互作用的不一致性度量

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Myra B. McGuinness
Joanne E. McKenzie
Andrew Forbes
Flora Hui
Keith R. Martin
Robert J. Casson
Amalia Karahalios

单阶段个体参与者数据元分析中治疗与协变量交互作用的不一致性度量

研究问题
在亚组人数不等或协变量连续时,如何计算单阶段个体数据元分析中治疗交互作用的 I²,并与两阶段模型比较?
方法与思路
作者扩展 I² 估计公式,在十四种模拟情景中改变试验间异质性、试验数量及每项试验人数,比较等价模型的偏差与精度。
材料陈述的贡献
摘要称,两类模型的 I² 偏差与精度相近,平均差为负一至零个百分点,但小样本模拟中差异可达十九点四个百分点。
阅读关注点
应核对单阶段与两阶段模型的等价条件、连续协变量的尺度处理,以及小样本下 I² 差异与不确定性如何报告。
阅读边界
这是 arXiv 预印本,同行评审及期刊接收未核实;摘要提供部分模拟结果,但未说明完整设计及公式,不能推广至任意元分析。

原文摘要

It is recommended that measures of between-study effect heterogeneity be reported when conducting individual-participant data meta-analyses (IPD-MA). Methods exist to quantify inconsistency between trials via I^2 (the percentage of variation in the treatment effect due to between-study heterogeneity) when conducting two-stage IPD-MA, and when conducting one-stage IPD-MA with approximately equal numbers of treatment and control group participants. We extend formulae to estimate I^2 when investigating treatment-covariate interactions with unequal numbers of participants across subgroups and/or continuous covariates. A simulation study was conducted to assess the agreement in values of I^2 between those derived from two-stage models using traditional methods and those derived from equivalent one-stage models. Fourteen scenarios differed by the magnitude of between-trial heterogeneity, the number of trials, and the average number of participants in each trial. Bias and precision of I^2 were similar between the one- and two-stage models. The mean difference in I^2 between equivalent models ranged between -1.0 and 0.0 percentage points across scenarios. However, disparities were larger in simulated datasets with smaller samples sizes with up to 19.4 percentage points difference between models. Thus, the estimates of I^2 derived from these extended methods can be interpreted similarly to those from existing formulae for two-stage models.

笔记与分组
相关领域论文